Journal of Thrombosis and Thrombolysis

, Volume 32, Issue 1, pp 1–8

Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease

  • Elisa Cangiano
  • Caterina Cavazza
  • Gianluca Campo
  • Marco Valgimigli
  • Gloria Francolini
  • Patrizia Malagutti
  • Claudio Pratola
  • Roberto Ferrari
Article

DOI: 10.1007/s11239-010-0543-8

Cite this article as:
Cangiano, E., Cavazza, C., Campo, G. et al. J Thromb Thrombolysis (2011) 32: 1. doi:10.1007/s11239-010-0543-8

Abstract

To test the role of necrosis, ischemia or both in bone marrow cells (BMC) mobilization in patients with cardiovascular disease. We studied three groups of patients: group 1, Iatrogenic Necrosis, with pure necrosis (28 patients undergoing transcatheter radiofrequency ablation); group 2, Ischemic Necrosis (30 patients with myocardial infarction); group 3, Pure Ischemia (24 patients with unstable angina). As control groups, we studied 27 patients with stable coronary artery disease (CAD), and 20 patients without CAD undergoing angiography for valvular diseases or cardiomiopathy. CD34 + cells and cytokines were evaluated at: T0 (baseline), 48 h and 5, 7, 10, 14 days thereafter. We observed a significant increase of CD34 + cells at T3 and T4 only in Iatrogenic Necrosis and Ischemic Necrosis group. The peak of mobilization was observed ten days after the necrotic event (2.8 ± 1.4 vs. 5.9 ± 1.9 in the group 1, P = 0.03; and 3 ± 1.5 vs. 5.6 ± 2 in the group 2, P = 0.04; respectively). We found a good correlation between CD34 + and vascular endothelial growth factor (VEGF) and stromal derived factor (SDF-1α) peak values (r = 0.77 and r = 0.63, respectively). At multivariable analysis, myocardial necrosis (OR 3.5, 95%CI 2.2–4.2, P < 0.01), VEGF (OR 2, 95%CI 1.1–3, P = 0.01 as above versus below median value), and SDF-1α (OR 1.6, 95%CI 1.1–2.5, P = 0.02 as above versus below median value) emerged as independent predictors of C34 + cells increase. Myocardial necrosis with simultaneous elevation of VEGF and SDF-1α causes a significant CD34 + cells mobilization in patients with cardiovascular disease.

Keywords

CD34 + cells Bone marrow cells Vascular endothelial factor Stromal derived factor Cytokines 

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Elisa Cangiano
    • 1
  • Caterina Cavazza
    • 1
  • Gianluca Campo
    • 1
  • Marco Valgimigli
    • 1
    • 2
  • Gloria Francolini
    • 2
  • Patrizia Malagutti
    • 1
  • Claudio Pratola
    • 1
  • Roberto Ferrari
    • 1
    • 2
  1. 1.U.O. Cardiologia, Cardiovascular InstituteAzienda Ospedaliero-Universitaria S.AnnaFerraraItaly
  2. 2.Cardiovascular Research Centre, Salvatore Maugeri FoundationIRCCS Lumezzane e FerraraFerraraItaly

Personalised recommendations